SECsense Logo

Cyclo Therapeutics, Inc. Financial Report: Insights & Stock Overview - Dec 2023

$CYTHW
Form 8-K
Filed on: 2023-12-26
Source
Cyclo Therapeutics, Inc. Financial Report: Insights & Stock Overview - Dec 2023

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK Number: 0000922247
  • SEC File Number: 001-39780
  • EIN: 59-3029743
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone Number: 386-418-8060
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share
    • Ticker Symbol: CYTH
    • Exchange: NASDAQ
  • Warrants:
    • Type: Warrants to purchase Common Stock
    • Ticker Symbol: CYTHW
    • Exchange: NASDAQ
  1. Reporting Period:
  • The report is dated December 26, 2023, indicating that it pertains to the same day.
  1. Contextual Identifiers:
  • Various context identifiers are provided for different elements, indicating the specific details regarding stock classes and their valuations:
    • Common Stock Par Value
    • Warrants to Purchase Common Stock.
  1. XML Schema Reference:
  • The report references an XML schema file (ctdh-20231226.xsd), which may define the structure and rules for the XBRL data included in the report.
  1. XBRL and Namespace Information:
  • The report employs XBRL (eXtensible Business Reporting Language) for structured data representation, and it includes multiple namespaces indicating the standards adhered to, such as US GAAP.

Insights:

  • Cyclo Therapeutics, Inc. is a publicly traded company on NASDAQ, indicating its compliance with SEC regulations and financial reporting standards.
  • The presence of warrants may indicate additional financing options for investors, which could impact shareholder value and company liquidity.
  • The report's focus on specific stock details and the use of XBRL suggests a formal and detailed approach to financial reporting, likely aimed at providing transparency and facilitating analysis by investors and analysts.

The information presents a snapshot of the company's financial standing and stock structure as of the reporting date, which is crucial for potential investors and stakeholders.